Abbott Q1 Profit and Revenue Beat Analyst Estimates
Abbott beat Q1 estimates with $11.16 billion in revenue. Results were aided by medical device sales and the acquisition of cancer-test maker Exact Sciences.
Xurve View
Insights:
Xurve View
ABBOTT LABORATORIES reported first-quarter financial results that exceeded Wall Street estimates, driven by the strength of its medical device division and its strategic expansion into the cancer diagnostics market.
